Pnc Financial Services Group, Inc. Beam Therapeutics Inc. Transaction History

Pnc Financial Services Group, Inc.

$148 Billion
Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,117 shares of BEAM stock, worth $46,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,117

Previous 2,012 5.22%

Holding current value

$46,976

Previous $49,000 6.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$21.55 - $30.35 $2,262 - $3,186	105 Added 5.22%	2,117 $52,000
Q3 2024 Nov 08, 2024	BUY	$22.57 - $33.14 $947 - $1,391	42 Added 2.13%	2,012 $49,000
Q2 2024 Aug 09, 2024	BUY	$21.22 - $32.66 $4,201 - $6,466	198 Added 11.17%	1,970 $46,000
Q1 2024 May 10, 2024	BUY	$23.46 - $45.07 $4,879 - $9,374	208 Added 13.3%	1,772 $58,000
Q4 2023 Feb 09, 2024	BUY	$17.69 - $30.76 $16,327 - $28,391	923 Added 143.99%	1,564 $42,000
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $6,833 - $9,640	297 Added 86.34%	641 $15,000
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $7,681 - $9,429	262 Added 319.51%	344 $10,000
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $994 - $1,610	33 Added 67.35%	82 $2,000
Q4 2022 Feb 10, 2023	SELL	$36.73 - $51.6 $587 - $825	-16 Reduced 24.62%	49 $1,000
Q3 2022 Nov 10, 2022	BUY	$39.79 - $70.31 $1,710 - $3,023	43 Added 195.45%	65 $3,000
Q2 2022 Aug 12, 2022	SELL	$29.86 - $62.36 $149,718 - $312,673	-5,014 Reduced 99.56%	22 $0
Q1 2022 May 12, 2022	SELL	$53.73 - $82.16 $376 - $575	-7 Reduced 0.14%	5,036 $288,000
Q4 2021 Feb 11, 2022	SELL	$68.02 - $99.06 $68,632 - $99,951	-1,009 Reduced 16.67%	5,043 $401,000
Q3 2021 Nov 05, 2021	BUY	$84.37 - $133.6 $20,248 - $32,064	240 Added 4.13%	6,052 $526,000
Q2 2021 Aug 06, 2021	BUY	$64.12 - $128.71 $21,095 - $42,345	329 Added 6.0%	5,812 $748,000
Q1 2021 May 07, 2021	BUY	$71.28 - $120.75 $9,337 - $15,818	131 Added 2.45%	5,483 $438,000
Q4 2020 Feb 12, 2021	BUY	$22.24 - $95.63 $7,828 - $33,661	352 Added 7.04%	5,352 $436,000
Q3 2020 Nov 06, 2020	BUY	$19.0 - $30.57 $95,000 - $152,850	5,000 New	5,000 $123,000

Others Institutions Holding BEAM

# of Institutions

252

Shares Held

78.5M

Call Options Held

304K

Put Options Held

142K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.56B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Beam Therapeutics Inc. Transaction History